Chargement en cours...
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide pandemic, and patients with the infection are referred to as having COVID‐19. Although COVID‐19 is commonly considered a respiratory disease, there is clearly a thrombotic potential that was not expected. The pathoph...
Enregistré dans:
| Publié dans: | Pharmacotherapy |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537066/ https://ncbi.nlm.nih.gov/pubmed/33006163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2465 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|